Plasma calprotectin to assess susceptibility to bloodstream infections during paediatric acute lymphoblastic leukaemia induction treatment
British Journal of Haematology · 2026-04 · 208 (4) · 1339-1346
DOI: 10.1111/bjh.70393 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 24.02.2026. Verfasst von Johanna Vævest Nymann Eriksen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukocyte L1 Antigen Complex, Bacteremia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Børnecancerfonden, Dagmar Marshalls Fond.
Abstract (Originalsprache)
Chemotherapy‐induced neutropenia, monitored by peripheral blood absolute neutrophil count (ANC), increases the risk of bloodstream infections (BSIs). However, ANC may not reflect the total neutrophil population, as it omits neutrophils at extravascular sites. We therefore evaluated plasma calprotectin, a neutrophil‐derived protein, as a complementary marker of neutropenia severity and BSI risk. In 114 children with acute lymphoblastic leukaemia (ALL) treated according to the NOPHO ALL2008 protocol, plasma calprotectin was measured weekly during the 4‐week anthracycline‐based induction therapy. Daily ANC and BSI events were obtained from medical records. All patients developed profound neutropenia (ANC
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Institute for Inflammation Research, Centre for Rheumatology and Spine Disease, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Department of Paediatrics, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: Mathias Rathe, Claus H Nielsen, Kjeld Schmigelow, Sarah Weischendorff
Förderung
- Børnecancerfonden
- Dagmar Marshalls Fond
Zitieren
APA
Eriksen, J. V. N., de Pietri, S., Rathe, M., Hasle, H., Enevold, C., Nielsen, C. H., Schmigelow, K., Moser, C., Müller, K., & Weischendorff, S. (2026). Plasma calprotectin to assess susceptibility to bloodstream infections during paediatric acute lymphoblastic leukaemia induction treatment. British Journal of Haematology, 208(4), 1339-1346. https://doi.org/10.1111/bjh.70393
Vancouver
Eriksen JVN, de Pietri S, Rathe M, Hasle H, Enevold C, Nielsen CH, et al. Plasma calprotectin to assess susceptibility to bloodstream infections during paediatric acute lymphoblastic leukaemia induction treatment. British Journal of Haematology. 2026;208(4):1339-1346. doi:10.1111/bjh.70393
BibTeX
@article{Eriksen2026,
author = {Eriksen, Johanna Vævest Nymann and de Pietri, Silvia and Rathe, Mathias and Hasle, Henrik and Enevold, Christian and Nielsen, Claus H and Schmigelow, Kjeld and Moser, Claus and Müller, Klaus and Weischendorff, Sarah},
title = {Plasma calprotectin to assess susceptibility to bloodstream infections during paediatric acute lymphoblastic leukaemia induction treatment},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {4},
pages = {1339--1346},
doi = {10.1111/bjh.70393}
}
EUVIMED